Market Tracker

05/03 8:14am ET

Albany Molecular Research Inc (NASDAQ:AMRI)

15.20
Delayed Data
As of May 02
 +0.15 / +1.00%
Today’s Change
13.71
Today|||52-Week Range
22.48
-23.43%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close15.05
Today’s open15.13
Day’s range14.88 - 15.24
Volume183,343
Average volume (3 months)288,358
Market cap$537.3M
Dividend yield--
Data as of 05/02/2016

Growth & Valuation

Earnings growth (last year)+30.00%
Earnings growth (this year)+9.38%
Earnings growth (next 5 years)+13.55%
Revenue growth (last year)+45.48%
P/E ratioNM
Price/Sales1.64
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...+0.18+2.86%
ARWRArrowhead Pharmaceut...+0.23+3.97%
AMRNAmarin Corporation P...+0.11+6.01%
RGNXRegenxbio Inc+0.49+4.70%
Data as of 05/02/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)$0.21
Annual revenue (last year)$402.4M
Annual profit (last year)-$2.3M
Net profit margin-0.57%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts